The use of cytokine inhibitors: A new therapeutic insight into heart failure

This publication has 65 references indexed in Scilit:

• Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages
  Life Sciences, 1996
• Interleukin-8 as a sensitive marker of unstable coronary artery disease
  The American Journal of Cardiology, 1996
• Cyclic AMP Is an Essential Factor in Immune Responses
  Biochemical and Biophysical Research Communications, 1995
• Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line
  Life Sciences, 1994
• Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemia
  Life Sciences, 1994
• Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
  Journal of Clinical Investigation, 1994
• Elevated plasma interleukin-6 levels in patients with acute myocardial infarction
  American Heart Journal, 1993
• Dihydropyridine Antagonists and Agonists of Calcium Channels Inhibit the Induction of Nitric Oxide Synthase by Endotoxin in Cultured Macrophages
  Biochemical and Biophysical Research Communications, 1993
• Effects of cytokines on the contractility of cultured cardiac myocytes
  International Journal of Immunopharmacology, 1993
• Modulation ofinterleukin‐1β production by cyclic AMP in human monocytes
  FEBS Letters, 1990